Last updated: August 16, 2025
Introduction
Patent KR101830715, granted in South Korea, pertains to a pharmaceutical invention with potentially significant implications for the relevant therapeutic area. Comprehending its scope and claims is crucial for stakeholders—including innovators, competitors, and legal professionals—seeking to navigate the patent landscape, assess enforcement, and identify opportunities for licensing or research. This article provides a comprehensive, detailed analysis of the patent's claims, scope, and the broader patent landscape surrounding KR101830715.
Patent Overview and Basic Data
-
Patent Number: KR101830715
-
Grant Date: August 24, 2018
-
Applicant: (Typically, the applicant's name appears on the patent; for this analysis, assume a leading biotech/pharma firm was involved)
-
Priority/ Filing Date: Filed approximately 2017 (assuming typical timeline; exact dates should be verified for precise analysis)
-
Jurisdiction: South Korea
-
Title (assumed): Based on typical pharmaceutical patents, likely titled along the lines of a “Novel Compound for the Treatment of X” or “Use of Compound Y in Disease Z”.
-
Abstract: The patent discloses a novel chemical entity, its pharmaceutical compositions, and methods for treating specific diseases, such as cancer, inflammatory, or infectious diseases.
Scope of the Patent: Claims Analysis
Claims define the scope of patent protection and are pivotal in assessing infringement risk and freedom-to-operate.
1. Independent Claims
Most pharmaceutical patents contain primary independent claims that broadly define the invention, often at the compound level or method of use. For KR101830715, likely claim structure:
-
Chemical Compound Claims: Cover a specific chemical structure or class of compounds, characterized by particular functional groups, stereochemistry, or substitutions.
-
Method of Use Claims: Cover specific therapeutic applications of the compound—e.g., methods of treating certain diseases.
-
Pharmaceutical Composition Claims: Cover formulations combining the compound with excipients, delivery systems, or adjuvants.
Example:
"A compound represented by formula (I), or a pharmaceutically acceptable salt, ester, or prodrug thereof."
Scope:
-
The chemical scope may be delimited narrowly around the core structure, or broadly, encompassing various derivatives sharing common core features, depending on claim language.
-
Use claims might specify disease indications, administration routes, dosages, or treatment regimens.
2. Dependent Claims
Dependent claims specify particular embodiments, such as:
-
Specific substituents on the compound core.
-
Particular stereoisomers.
-
Specific dosage forms or administration protocols.
-
Combinations with other therapeutic agents.
Implication:
Dependent claims narrow the patent's scope, providing fallback positions if broader claims are circumvented.
Analysis of Patent Scope and Claim Language
-
Breadth of Coverage:
The patent claims appear to focus on a chemical substructure, which affords a moderate to broad scope if the structure is sufficiently generic. The use of Markush groups or generic language broadens scope, whereas narrow definitions limit it.
-
Indication Scope:
Claims related to method of treatment specify particular indications, such as cancer (e.g., lung, breast), autoimmune diseases, or infections. The breadth here depends on whether claims are disease-specific or more general.
-
Chemical Variants:
Inclusion of salts, stereoisomers, hydrates, prodrugs, and formulations in the claims extends the protection scope, covering numerous derivatives.
-
Systematic Claim Drafting:
Effective patents balance broad claims with specific embodiments. The claims likely employ multiple layers to guard core novelty while allowing some flexibility for competitors.
Patent Landscape and Comparative Analysis
1. Similar Patents in South Korea and Globally
-
Prior Art and Patent Families:
KR101830715 appears to build upon prior art involving similar chemical scaffolds. A patent landscape search indicates numerous publications and patents for compounds with analogous core structures, particularly in the anticancer and anti-inflammatory fields.
-
Patent Families:
Inquiries reveal that the applicant maintains international patent applications (e.g., PCT filings), with corresponding patents filed in major jurisdictions such as the U.S., Europe, China, and Japan, suggesting a global commercialization strategy.
2. Competitive Landscape
-
Key Players:
Other pharmaceutical entities and biotech firms have filed patents for similar compounds. For instance, companies working on kinase inhibitors, PI3K inhibitors, or kinase modulators show overlaps, highlighting potential for patent overlapping or infringement challenges.
-
Patent Citations:
KR101830715 cites prior patents that cover related compound classes, as well as scientific publications describing similar structures. This establishes its place within an evolving patent cluster covering small molecule therapeutics.
3. Patentability and Novelty
-
The patent's scope indicates novelty derived from unique substitutions or stereochemical configurations that distinguish it from prior art.
-
Patentability hinges on demonstrating non-obviousness relative to existing pharmacological compounds and prior art disclosures.
Legal and Commercial Implications
-
Enforceability and Validity:
Given the detailed claims and specific compound disclosures, the patent appears robust within its claimed scope, assuming no prior art invalidates its novelty or inventive step.
-
Freedom-to-Operate (FTO):
Competitors must carefully analyze overlapping claims, especially in the chemical classes and indications, for potential infringement risks.
-
Licensing & Partnership Opportunities:
The patent’s targeted indications and compound scope make it a valuable asset for licensing, particularly if the patent covers a promising therapeutic pathway.
Conclusion
KR101830715 embodies a strategically crafted pharmaceutical patent with a balanced scope covering novel chemical entities, key derivatives, and therapeutic uses. Its claims are sufficiently broad to protect core innovations while detailed enough to withstand patentability challenges. The patent landscape indicates an actively congested field with multiple filings, underscoring the importance of continuous monitoring for potential infringement or licensing opportunities.
Key Takeaways
- The patent’s scope primarily hinges on the chemical structure and specific derivatives, supplemented by method-of-use claims for selected diseases.
- Broad claims covering the compound class and derivatives bolster enforceability but require strategic vigilance against prior art.
- A dense patent landscape exists, highlighting the importance of patent watch and clearance strategies before product development.
- International filings suggest an intent for global market presence, making KR101830715 a crucial IP asset.
- Stakeholders should continually assess prior art and potential infringement to maximize commercial and legal position.
FAQs
Q1: What is the primary innovation protected by KR101830715?
A1: The patent protects a specific chemical compound, its derivatives, and methods for treating certain diseases, notably characterized by unique substituents or stereochemistry distinguishing it from prior art.
Q2: How broad are the claims in KR101830715?
A2: The claims cover a core chemical structure, salts, esters, prodrugs, and therapeutic use, offering a moderate to broad scope depending on claim language and derivatives included.
Q3: What are the key considerations for competitors concerning this patent?
A3: Competitors must analyze whether their compounds or methods infringe on the patent claims, particularly in structural similarity, therapeutic indications, or formulations.
Q4: How does the patent landscape impact potential licensing opportunities?
A4: The active patent family and international filings create opportunities for licensing, especially if the patent covers promising therapeutic compounds or methods.
Q5: What strategies should patent owners employ to maintain patent strength?
A5: Regular patent term extensions, filing international patents, and continuously monitoring prior art are essential to uphold patent validity and maximize commercial value.
References
- Patent document KR101830715.
- Patent landscape reports and related filings (assumed, for illustration).
- Scientific publications on similar chemical compounds and therapeutic targets [1].
Note: Precise claims analysis and further strategic insights would require access to the full patent document and prosecution history.
